Elsevier collaborates with Beijing University of Chinese Medicine to enable deeper research into traditional...
As global interest in traditional and alternative medicine grows, Elsevier, the global information analytics business...
Enhanced ICP-MS Triple Quadrupole Technology for Ultra-trace Analysis
Semiconductor wafer fabrication plants and ultra-high purity chemical suppliers can now strengthen their monitoring of...
Saneca Pharma renews Pharmascience agreement following successful quality audit
Contract development and manufacturing organisation (CDMO) Saneca Pharma has renewed an agreement with Pharmascience Inc,...
CRF Health Scoops 2018 TrialConsent® Hat Trick as CARE Award Finalist
CRF Health, the leading provider of patient-centered eSource for the life sciences industry, announced that...
Biotech uses New Technology to fight Cardiovascular Diseases
Despite significant technological advances in technology, cardiovascular diseases (CVDs) remain the number one cause of...
Alma Lasers Inc., receives new FDA clearance soprano ICE platform, Indicating a new era...
Alma Lasers, a subsidiary of Sisram Medical Ltd , the leading global innovator of laser...
Study claims the Importance of familiarizing the risks and benefits of phase 1 trials...
On average, 1 in 10 children who enroll in pediatric phase I cancer trials are...
FDA Approval for Allegra’s filing for supplemental new drug application LILETTA®
Allergan plc, a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical...
AbbVie and Voyager Therapeutics collaborates for Neurodegenerative Diseases
AbbVie , a global biopharmaceutical company, and Voyager Therapeutics, Inc. , a clinical-stage gene therapy...
Astrazeneca’s Imfinzi for unresectable Stage III non-small cell lung cancer gets FDA approval
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US...
